Brief Summary of Mifegymiso in Canada

  • In July of 2015, Health Canada approved the abortion pill Mifegymiso, the Canadian brand name for the combination of Mifepristone and Misoprostol.
  • Its roll-out did not effectively start until January 2017. Mifegymiso is now available in a limited number of locations. Click here to find a prescriber in your area. Some prescribers and pharmacies are not listed on our public directory and so, if you wish to know if someone in your region prescribes or dispenses Mifegymiso, please contact the Access Line at 1-888-642-2725.
  • Mifegymiso’s cost hovers between 300$ and 450$ which means that, without cost coverage, medical abortion using this combination of drugs remains inaccessible for most people.
  • On April 20th 2017, the CADTH Canadian Drug Expert Committee made its final recommendation on the newly approved abortion pill. The expert committee recommended provincial and territorial cost reimbursement of Mifegymiso.
  • Currently, three provinces have pledged universal coverage for Mifegymiso: New Brunswick, Alberta and Ontario. The Non-Insured Health Benefits will also be covering the costs of the abortion pill for First Nations people living on reserves and Inuit people. It is not yet clear when the combination of pills will effectively be available for free to those with provincial health insurance in these provinces or to NIHB patients.
  • Health Canada’s unnecessary restrictions around the prescribing and dispensing of Mifegymiso continue to hamper access to medical abortion. See Action Canada for Sexual Health and rights “asks” to support the most effective Mifegymiso roll-out and increased access to abortion in Canada
  • Mifegymiso distributor Celopharma submitted a Supplemental New Drug Submission (SNDS) to have several of the Health Canada restrictions reviewed. A decision is anticipated in the Fall of 2017.
  • Health Canada makes an announcement on the easing of some of its restrictions. Pharmacists are no longer required to take the SOGC training before dispensing Mifegymiso and the distribution systems are clearly under the jurisdiction of each provincial professional bodies representing physicians and pharmacists.